Michael Morabito
Stock Analyst at Chardan Capital
(0.03)
# 4,433
Out of 5,044 analysts
9
Total ratings
11.11%
Success rate
-23.25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Morabito
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AKRO Akero Therapeutics | Maintains: Buy | $79 → $81 | $54.00 | +50.00% | 2 | Mar 17, 2021 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Buy | $202 → $203 | $421.60 | -51.85% | 2 | Feb 26, 2021 | |
| ETNB 89bio | Maintains: Buy | $59 → $95 | $14.84 | +540.16% | 3 | Sep 15, 2020 | |
| VKTX Viking Therapeutics | Maintains: Buy | $15 → $20 | $35.22 | -43.21% | 2 | Aug 31, 2020 |
Akero Therapeutics
Mar 17, 2021
Maintains: Buy
Price Target: $79 → $81
Current: $54.00
Upside: +50.00%
Madrigal Pharmaceuticals
Feb 26, 2021
Maintains: Buy
Price Target: $202 → $203
Current: $421.60
Upside: -51.85%
89bio
Sep 15, 2020
Maintains: Buy
Price Target: $59 → $95
Current: $14.84
Upside: +540.16%
Viking Therapeutics
Aug 31, 2020
Maintains: Buy
Price Target: $15 → $20
Current: $35.22
Upside: -43.21%